2020 / 04

Next Paper
DOI: 10.47183/mes.2020.020

ORIGINAL RESEARCH

Using experimental ex vivo models to develop COVID-19 pathogenetic therapy and complications prevention agents

Laptev DS, Petunov SG, Nechaykina OV, Bobkov DV, Radilov AS
About authors

Research Institute of Hygiene, Occupational Pathology and Human Ecology Leningrad Region, Russia

Correspondence should be addressed: Denis S. Laptev
st. Kapitolovo, gor. pos. Kuzmolovsky, 93, Vsevolozhsky rajon, 188663; ur.liam@nedpal

About paper

Author contribution: Laptev DS — experimental part, information collection, data processing; Petunov SG — data processing and interpretation, general guidance; Nechaykina OV — experimental part, information collection; Bobkov DV — data processing; Radilov AS — data processing and interpretation.

Compliance with ethical standards: all work with animals was carried out in conformity to the provisions of the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes.

Received: 2020-09-15 Accepted: 2020-12-25 Published online: 2020-12-12
|
No data available...